| Glioblastoma |
1 |
0.77 |
| Head and Neck Cancer |
0 |
1 |
| Brain Tumor |
0 |
0.75 |
| Tumor |
0 |
0.73 |
| Brain Cancer |
0 |
0.51 |
| Breast Cancer |
0 |
0.48 |
| Pituitary Tumor |
0 |
0.48 |
| Toxicology |
0 |
0.45 |
| Lung Cancer |
0 |
0.44 |
| Brain |
0 |
0.42 |
| Cancer |
0 |
0.37 |
| Triple Negative Breast Cancer |
0 |
0.27 |
| Chemotherapy |
0 |
0.16 |
| Clinical Research |
0 |
0.16 |
| Traumatic Brain Injury |
0 |
0.15 |
| Wound Management |
0 |
0.14 |
| Care and Maintenance of Vision |
0 |
0.12 |
| Cataract |
0 |
0.11 |
| Head Injury |
0 |
0.11 |
| Autopsy |
0 |
0.1 |
| Hospital |
0 |
0.1 |
| Injury |
0 |
0.1 |
| Radiation Therapy |
0 |
0.1 |
| Social Determinants of Health |
0 |
0.07 |
| A-Scan Biometry |
0 |
0.05 |
| Breast |
0 |
0.05 |
| Food and Drug Administration (FDA) |
0 |
0.05 |
| Grant |
0 |
0.05 |
| Health Care Quality, Access, and Evaluation |
0 |
0.05 |
| Lung |
0 |
0.05 |
| Neurooncology |
0 |
0.05 |
| Neurosurgery |
0 |
0.05 |
| New York |
0 |
0.05 |
| Pituitary Gland |
0 |
0.05 |
| Scalp |
0 |
0.05 |
| Scan |
0 |
0.05 |
| Surgery |
0 |
0.05 |
| Translational Research |
0 |
0.05 |